ロード中...
Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles
PURPOSE: Thymosin beta 4 (Tβ4) has multiple beneficial facets for myocardial injury, but its efficiency is limited by the low local concentration within the infarct. Here, we established a Tβ4 delivery system for cardiac repair based on the interaction between the abundant fibrin in the infarct zone...
保存先:
| 出版年: | Int J Nanomedicine |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396927/ https://ncbi.nlm.nih.gov/pubmed/28442910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S131949 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|